There was no statistically significant association between GCK rs1799884, GCKR rs780094 and DGKB/TMEM195 rs2191349 polymorphisms and the development of post-transplant diabetes mellitus in kidney transplant patients treated with tacrolimus (Table 3 and Table 4). This evidence concerns the gene AGMO and diabetes mellitus.